Effect of Resistance Training on Physical Function During Chemotherapy in Colon Cancer.

Colonic neoplasms exercise frailty mobility disability sarcopenia

Journal

JNCI cancer spectrum
ISSN: 2515-5091
Titre abrégé: JNCI Cancer Spectr
Pays: England
ID NLM: 101721827

Informations de publication

Date de publication:
16 Jul 2024
Historique:
received: 14 02 2024
revised: 25 06 2024
accepted: 06 07 2024
medline: 16 7 2024
pubmed: 16 7 2024
entrez: 16 7 2024
Statut: aheadofprint

Résumé

The decline of physical function during chemotherapy predicts poor quality of life and premature death. It is unknown if resistance training prevents physical function decline during chemotherapy in colon cancer survivors. This multicenter trial randomized 181 colon cancer survivors receiving postoperative chemotherapy to home-based resistance training or usual care control. Physical function outcomes included the short physical performance battery (SPPB), isometric handgrip strength, and the physical function subscale of the Medical Outcomes Short-Form 36-item questionnaire. Mixed models for repeated measures quantified estimated treatment differences (ETD). At baseline, subjects had a mean (SD) age of 55.2 years (12.8); 67 (37%) were ≥60 years, and 29 (16%) had a composite SPPB score ≤9. Compared with control, resistance training did not improve the composite SPPB score [ETD: -0.01 (95% CI: -0.32, 0.31); P = 0.98], or the SPPB scores for balance [ETD: 0.01 (95% CI: -0.10, 0.11); P = 0.93], gait speed [ETD: 0.08 (95% CI: -0.06, 0.22) P = 0.28], and sit-to-stand [ETD: -0.08 (95% CI: -0.29, 0.13); P = 0.46]. Compared with control, resistance training did not improve isometric handgrip strength [ETD: 1.50 kg (95% CI: -1.06, 4.05); P = 0.25] or self-reported physical function [ETD: -3.55 (95% CI: -10.03, 2.94); P = 0.28]. The baseline SPPB balance score [r=0.21 (95% CI: 0.07, 0.35)] and handgrip strength [r=0.23 (95% CI: 0.09, 0.36)] correlated with chemotherapy relative dose intensity. Among colon cancer survivors with relatively high physical functioning, randomization to home-based resistance training did not prevent physical function decline during chemotherapy. NCT03291951.

Sections du résumé

BACKGROUND BACKGROUND
The decline of physical function during chemotherapy predicts poor quality of life and premature death. It is unknown if resistance training prevents physical function decline during chemotherapy in colon cancer survivors.
METHODS METHODS
This multicenter trial randomized 181 colon cancer survivors receiving postoperative chemotherapy to home-based resistance training or usual care control. Physical function outcomes included the short physical performance battery (SPPB), isometric handgrip strength, and the physical function subscale of the Medical Outcomes Short-Form 36-item questionnaire. Mixed models for repeated measures quantified estimated treatment differences (ETD).
RESULTS RESULTS
At baseline, subjects had a mean (SD) age of 55.2 years (12.8); 67 (37%) were ≥60 years, and 29 (16%) had a composite SPPB score ≤9. Compared with control, resistance training did not improve the composite SPPB score [ETD: -0.01 (95% CI: -0.32, 0.31); P = 0.98], or the SPPB scores for balance [ETD: 0.01 (95% CI: -0.10, 0.11); P = 0.93], gait speed [ETD: 0.08 (95% CI: -0.06, 0.22) P = 0.28], and sit-to-stand [ETD: -0.08 (95% CI: -0.29, 0.13); P = 0.46]. Compared with control, resistance training did not improve isometric handgrip strength [ETD: 1.50 kg (95% CI: -1.06, 4.05); P = 0.25] or self-reported physical function [ETD: -3.55 (95% CI: -10.03, 2.94); P = 0.28]. The baseline SPPB balance score [r=0.21 (95% CI: 0.07, 0.35)] and handgrip strength [r=0.23 (95% CI: 0.09, 0.36)] correlated with chemotherapy relative dose intensity.
CONCLUSION CONCLUSIONS
Among colon cancer survivors with relatively high physical functioning, randomization to home-based resistance training did not prevent physical function decline during chemotherapy.
CLINICAL TRIAL REGISTRATION BACKGROUND
NCT03291951.

Identifiants

pubmed: 39012500
pii: 7714696
doi: 10.1093/jncics/pkae058
pii:
doi:

Banques de données

ClinicalTrials.gov
['NCT03291951']

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© The Author(s) 2024. Published by Oxford University Press.

Auteurs

Justin C Brown (JC)

Pennington Biomedical Research Center, 6400 Perkins Rd, Baton Rouge, LA 70808, USA.
LSU Health Sciences Center New Orleans School of Medicine, 1901 Perdido St, New Orleans, LA 70112, USA.
Stanley S. Scott Cancer Center, Louisiana State University Health Sciences Center, 533 Bolivar St, New Orleans, LA, 70112, USA.

Shengping Yang (S)

Pennington Biomedical Research Center, 6400 Perkins Rd, Baton Rouge, LA 70808, USA.

Stephanie L E Compton (SLE)

Pennington Biomedical Research Center, 6400 Perkins Rd, Baton Rouge, LA 70808, USA.

Kristin L Campbell (KL)

University of British Columbia, Vancouver, 2177 Westbrook Mall, British Columbia, V6T 1Z1, Canada.

Elizabeth M Cespedes Feliciano (EM)

Kaiser Permanente Northern California, 2000 Broadway, Oakland, CA 94612, USA.

Sara Quinney (S)

Indiana University School of Medicine, 950 W Walnut St, Indianapolis, IN, 46202, USA.

Barbara Sternfeld (B)

Kaiser Permanente Northern California, 2000 Broadway, Oakland, CA 94612, USA.

Bette J Caan (BJ)

Indiana University School of Medicine, 950 W Walnut St, Indianapolis, IN, 46202, USA.

Jeffrey A Meyerhardt (JA)

Dana-Farber Cancer Institute, 450 Brookline Ave, Boston, MA 02215, USA.

Kathryn H Schmitz (KH)

University of Pittsburgh, 5150 Centre Ave, Pittsburgh, PA 15232, USA.

Classifications MeSH